Literature DB >> 18548271

Expression of cTnI-R145G affects shortening properties of adult rat cardiomyocytes.

Stephanie Reis1, Christoph Littwitz, Sebastian Preilowski, Andreas Mügge, Ger J M Stienen, Lutz Pott, Kornelia Jaquet.   

Abstract

The R145G amino acid exchange in the inhibitory subunit (cTnI) of cardiac troponin, which regulates muscle contraction, is related to familial hypertrophic cardiomyopathy. Information on its impact on contractility of adult cardiomyocytes is scarce. We studied shortening of adult rat cardiomyocytes before and during ss-adrenergic stimulation using adenovirus-driven expression of human cTnI-wild type (wt) and cTnI-R145G. Baseline sarcomere shortening was significantly decreased by cTnI-R145G expression. Upon ss-adrenergic stimulation using isoproterenol (ISO), nearly identical amplitudes of shortening were obtained with cells expressing cTnI-R145G and control cardiomyocytes (native and cTnI-wt). However, rates of shortening and relengthening were depressed in cTnI-R145G-expressing cells but were comparable to those of control cells upon addition of forskolin or ISO and ICI118,551. This indicates that cTnI-R145G expression influences the response to ss-adrenergic stimulation dependent on the receptor subtype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548271     DOI: 10.1007/s00424-008-0487-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  32 in total

1.  Cardiology patient pages. Hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

2.  Chimera analysis of troponin I domains that influence Ca(2+)-activated myofilament tension in adult cardiac myocytes.

Authors:  M V Westfall; F P Albayya; I I Turner; J M Metzger
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

Review 3.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

4.  Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.

Authors:  J James; Y Zhang; H Osinska; A Sanbe; R Klevitsky; T E Hewett; J Robbins
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

5.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

Review 6.  Molecular and cellular aspects of troponin cardiomyopathies.

Authors:  Aldrin V Gomes; James D Potter
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

7.  Role of beta 1- and beta 2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes.

Authors:  Klaus Pönicke; Ingrid Heinroth-Hoffmann; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-15       Impact factor: 3.000

8.  Altered pattern of post-rest contractions in hypertrophied rabbit ventricle.

Authors:  I R Wendt; C L Gibbs; G Kotsanas; I R Young
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

9.  Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes.

Authors:  So-ichiro Yasuda; Pierre Coutu; Sakthivel Sadayappan; Jeffrey Robbins; Joseph M Metzger
Journal:  Circ Res       Date:  2007-07-05       Impact factor: 17.367

10.  Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C.

Authors:  R Zhang; J Zhao; J D Potter
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

View more
  5 in total

1.  Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.

Authors:  David Dweck; Marcos A Sanchez-Gonzalez; Audrey N Chang; Raul A Dulce; Crystal-Dawn Badger; Andrew P Koutnik; Edda L Ruiz; Brittany Griffin; Jingsheng Liang; Mohamed Kabbaj; Frank D Fincham; Joshua M Hare; J Michael Overton; Jose R Pinto
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

Review 2.  Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

Authors:  Yuanhua Cheng; Michael Regnier
Journal:  Arch Biochem Biophys       Date:  2016-02-04       Impact factor: 4.013

3.  Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation.

Authors:  Yuanhua Cheng; Vijay Rao; An-Yue Tu; Steffen Lindert; Dan Wang; Lucas Oxenford; Andrew D McCulloch; J Andrew McCammon; Michael Regnier
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

4.  Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.

Authors:  Yuanhua Cheng; Steffen Lindert; Lucas Oxenford; An-Yue Tu; Andrew D McCulloch; Michael Regnier
Journal:  J Phys Chem B       Date:  2016-05-18       Impact factor: 2.991

5.  Soluble adenylyl cyclase: A novel player in cardiac hypertrophy induced by isoprenaline or pressure overload.

Authors:  Ilona Schirmer; Tippaporn Bualeong; Heidi Budde; Diana Cimiotti; Avinash Appukuttan; Nicole Klein; Philip Steinwascher; Peter Reusch; Andreas Mügge; Rainer Meyer; Yury Ladilov; Kornelia Jaquet
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.